Different Methods of Capecitabine in Patients With Non-PCR After Neoadjuvant Therapy for TNBC

NCT06700382 · clinicaltrials.gov ↗

RECRUITING

Status

1166

Enrollment

OTHER

Sponsor class

Conditions

Triple Negative Breast Cancer

Interventions

DRUG: capecitabine

Sponsor

Shu Wang